Emergent BioSolutions Inc. - 10-Q Filing
Emergent BioSolutions reports Q3 2026 results amid ongoing organizational restructuring and asset disposal activities.
Tickers: $EBS
Read the full article at SEC EDGAR
Part of the story Emergent BioSolutions Inc. - 10-Q Filing (3 articles)